Find trials
Search tips

Ovarian Cancer Microbiome Signatures

Overview

About this study

The purpose of this study is to characterize the microbiome in the genital tract and in the peritoneal cavity of subjects with ovarian, fallopian tube, and primary peritoneal cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing surgery for suspicion of ovarian, fallopian tube, and primary peritoneal cancer

Exclusion Criteria:

  • Patients who had received neoadjuvant therapy (chemotherapy-radiotherapy) and/or treatment with antibiotics during the 3 months prior to surgery
  • Women with prior hysterectomy

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Mariani, M.D., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20306522

Mayo Clinic Footer